Symbols / PAVM Stock $9.17 -2.24% PAVmed Inc.

Healthcare • Medical Devices • United States • NCM
PAVM (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
About

PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York

Stock Fundamentals
Scroll to Statements
Market Cap 57.91M Enterprise Value 82.32M Income -3.77M Sales 71.00K Book/sh 10.01 Cash/sh 0.31
Dividend Yield Payout 0.00% Employees 41 IPO P/E Forward P/E -3.35
PEG P/S 815.66 P/B 0.92 P/C EV/EBITDA -3.79 EV/Sales 1159.42
Quick Ratio 0.13 Current Ratio 0.17 Debt/Eq 59.86 LT Debt/Eq EPS (ttm) -5.63 EPS next Y -2.74
EPS Growth Revenue Growth 4.20% Earnings 2026-05-14 ROA -39.24% ROE -32.34% ROIC
Gross Margin -207.04% Oper. Margin -130.83% Profit Margin 5.65% Shs Outstand 6.32M Shs Float 2.75M Short Float 0.38%
Short Ratio 1.27 Short Interest 52W High 28.44 52W Low 6.00 Beta 0.81 Avg Volume 81.50K
Volume 16.46K Target Price $40.50 Recom Strong_buy Prev Close $9.38 Price $9.17 Change -2.24%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$40.50
Mean price target
2. Current target
$9.17
Latest analyst target
3. DCF / Fair value
$-39.90
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$9.17
Low
$16.00
High
$65.00
Mean
$40.50

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-09 main Ascendiant Capital Buy → Buy $65
2025-12-10 main Ascendiant Capital Buy → Buy $17
2025-10-06 main Ascendiant Capital Buy → Buy $20
2025-06-06 main Ascendiant Capital Buy → Buy $19
2025-04-21 main Ascendiant Capital Buy → Buy $20
2024-12-09 main Ascendiant Capital Buy → Buy $19
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-02 MCGRATH DENNIS M President 180,000 $0.00 $0
2026-04-02 AKLOG LISHAN Chief Executive Officer 350,000 $0.00 $0
2026-04-02 GLENNON MICHAEL J Director 13,930 $0.00 $0
2026-04-02 AGRAWAL SUNDEEP Director 13,930 $0.00 $0
2026-04-02 WHITE DEBRA JAYNE Director 13,930 $0.00 $0
2026-04-02 O'NEIL SHAUN Chief Operating Officer 110,000 $0.00 $0
2026-04-02 BAXTER TIMOTHY E Director 13,930 $0.00 $0
2026-04-02 GORDON MICHAEL ADAM General Counsel 110,000 $0.00 $0
2026-04-02 LEE VICTORIA TOU-HO Officer 70,000 $0.00 $0
2025-09-30 MCGRATH DENNIS M President 150,000
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.07
-97.63%
3.00
+22.15%
2.45
+550.40%
0.38
Operating Revenue
0.07
-97.63%
3.00
+22.15%
2.45
+550.40%
0.38
Cost Of Revenue
0.22
-95.50%
4.84
-24.61%
6.42
+77.64%
3.61
Reconciled Cost Of Revenue
0.11
-97.31%
4.20
-23.74%
5.51
+87.32%
2.94
Gross Profit
-0.15
+92.03%
-1.84
+53.50%
-3.97
-22.58%
-3.24
Operating Expense
21.24
-50.06%
42.53
-34.39%
64.83
-26.21%
87.85
Research And Development
4.49
-24.28%
5.93
-58.45%
14.28
-43.66%
25.34
Selling General And Administration
17.17
-52.51%
36.15
-25.51%
48.53
-20.09%
60.73
Selling And Marketing Expense
0.92
-92.11%
11.63
-33.87%
17.58
-8.98%
19.32
General And Administrative Expense
16.25
-33.74%
24.52
-20.75%
30.95
-25.27%
41.41
Other Gand A
16.25
-33.74%
24.52
-20.75%
30.95
-25.27%
41.41
Other Operating Expenses
-0.42
-281.65%
-0.11
Total Expenses
21.46
-54.70%
47.37
-33.51%
71.25
-22.10%
91.46
Operating Income
-21.39
+51.80%
-44.38
+35.49%
-68.80
+24.47%
-91.09
Total Operating Income As Reported
-21.81
+50.98%
-44.49
+35.33%
-68.80
+24.47%
-91.09
EBITDA
-2.34
-107.90%
29.67
+139.17%
-75.74
+23.88%
-99.50
Normalized EBITDA
-2.29
+94.00%
-38.08
+47.52%
-72.57
+22.85%
-94.07
Reconciled Depreciation
0.10
-91.24%
1.20
-59.14%
2.93
+19.33%
2.46
EBIT
-2.45
-108.60%
28.47
+136.19%
-78.67
+22.84%
-101.96
Total Unusual Items
-0.06
-100.09%
67.75
+2235.94%
-3.17
+41.63%
-5.43
Total Unusual Items Excluding Goodwill
-0.06
-100.09%
67.75
+2235.94%
-3.17
+41.63%
-5.43
Special Income Charges
-0.06
-100.09%
67.75
+2535.37%
-2.78
+48.80%
-5.43
Other Special Charges
0.06
-98.72%
4.54
+19.91%
3.78
-30.40%
5.43
Net Income
0.40
-98.99%
39.79
+162.00%
-64.17
+27.88%
-88.98
Pretax Income
-2.47
-108.69%
28.43
+135.86%
-79.26
+23.22%
-103.24
Net Non Operating Interest Income Expense
0.01
-96.17%
0.21
+348.81%
-0.08
+92.45%
-1.11
Interest Expense Non Operating
0.02
-53.33%
0.04
-92.36%
0.59
-54.02%
1.28
Net Interest Income
0.01
-96.17%
0.21
+348.81%
-0.08
+92.45%
-1.11
Interest Expense
0.02
-53.33%
0.04
-92.36%
0.59
-54.02%
1.28
Interest Income Non Operating
0.03
-88.58%
0.25
-49.70%
0.51
+198.82%
0.17
Interest Income
0.03
-88.58%
0.25
-49.70%
0.51
+198.82%
0.17
Other Income Expense
18.91
-73.95%
72.60
+799.11%
-10.38
+5.93%
-11.04
Other Non Operating Income Expenses
10.49
+143.23%
4.31
+159.79%
-7.21
-28.67%
-5.61
Gain On Sale Of Security
0.46
+218.46%
-0.39
+69.36%
-1.27
Gain On Sale Of Business
0.00
-100.00%
72.29
0.00
Tax Provision
0.00
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-2.47
-108.69%
28.43
+135.86%
-79.26
+23.22%
-103.24
Net Income From Continuing Operation Net Minority Interest
0.40
-98.99%
39.79
+162.00%
-64.17
+27.88%
-88.98
Net Income From Continuing And Discontinued Operation
0.40
-98.99%
39.79
+162.00%
-64.17
+27.88%
-88.98
Net Income Continuous Operations
-2.47
-108.69%
28.43
+135.86%
-79.26
+23.22%
-103.24
Minority Interests
2.87
-74.74%
11.36
-24.68%
15.09
+5.84%
14.26
Normalized Income
0.46
+101.64%
-27.96
+54.16%
-61.00
+26.99%
-83.55
Net Income Common Stockholders
-3.77
-111.81%
31.97
+148.24%
-66.27
+25.76%
-89.26
Otherunder Preferred Stock Dividend
0.00
-100.00%
1.79
0.00
Diluted EPS
-5.63
-137.53%
15.00
+105.46%
-274.80
+39.06%
-450.90
Basic EPS
-5.63
-105.80%
97.11
+135.34%
-274.80
+39.06%
-450.90
Basic Average Shares
0.67
+79.61%
0.37
+54.86%
0.24
+21.78%
0.20
Diluted Average Shares
0.67
+79.61%
0.37
+54.86%
0.24
+21.78%
0.20
Diluted NI Availto Com Stockholders
-3.77
-111.65%
32.39
+148.88%
-66.27
+25.76%
-89.26
Average Dilution Earnings
0.00
-100.00%
0.43
Amortization
0.00
-100.00%
0.56
-72.34%
2.02
+13.28%
1.78
Amortization Of Intangibles Income Statement
0.00
-100.00%
0.56
-72.34%
2.02
+13.28%
1.78
Depreciation Amortization Depletion Income Statement
0.00
-100.00%
0.56
-72.34%
2.02
+13.28%
1.78
Depreciation And Amortization In Income Statement
0.00
-100.00%
0.56
-72.34%
2.02
+13.28%
1.78
Earnings From Equity Interest
8.48
+1494.55%
0.53
0.00
Gain On Sale Of PPE
0.00
-100.00%
1.00
0.00
Preferred Stock Dividends
4.17
-46.65%
7.83
+2474.01%
0.30
+8.19%
0.28
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
38.81
+26.59%
30.66
-7.42%
33.12
-38.65%
53.98
Current Assets
2.56
+18.16%
2.16
-91.17%
24.50
-44.23%
43.93
Cash Cash Equivalents And Short Term Investments
1.54
+29.79%
1.19
-93.97%
19.64
-50.59%
39.74
Cash And Cash Equivalents
1.54
+29.79%
1.19
-93.97%
19.64
-50.59%
39.74
Cash Financial
1.54
+29.79%
1.19
-93.97%
19.64
-50.59%
39.74
Receivables
0.01
-16.67%
0.02
-70.49%
0.06
+258.82%
0.02
Accounts Receivable
0.01
-16.67%
0.02
-70.49%
0.06
+258.82%
0.02
Inventory
0.24
-10.15%
0.27
-50.65%
0.54
+106.51%
0.26
Raw Materials
0.24
-10.15%
0.27
+1.92%
0.26
+74.00%
0.15
Prepaid Assets
0.77
+10.07%
0.69
-83.68%
4.26
+9.09%
3.90
Other Current Assets
Total Non Current Assets
36.26
+27.23%
28.50
+230.54%
8.62
-14.25%
10.05
Net PPE
2.08
-21.58%
2.65
-56.18%
6.05
+10.24%
5.49
Gross PPE
3.44
-11.96%
3.90
-49.75%
7.77
+23.40%
6.30
Accumulated Depreciation
-1.36
-8.38%
-1.25
+27.11%
-1.72
-112.75%
-0.81
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
0.88
+3.66%
0.85
-31.00%
1.23
+5.67%
1.16
Construction In Progress
0.00
+0.00%
0.00
-87.50%
0.02
-46.67%
0.03
Other Properties
2.56
-16.31%
3.05
-53.19%
6.52
+27.86%
5.10
Leases
0.00
+0.00%
0.00
-50.00%
0.00
+0.00%
0.00
Goodwill And Other Intangible Assets
0.00
-100.00%
1.42
-58.66%
3.44
Other Intangible Assets
1.42
-58.66%
3.44
Investments And Advances
34.12
+33.09%
25.64
0.00
Long Term Equity Investment
34.12
+33.09%
25.64
0.00
Other Non Current Assets
0.06
-73.08%
0.21
-81.87%
1.15
+2.32%
1.12
Total Liabilities Net Minority Interest
16.51
-56.19%
37.69
-34.03%
57.14
+32.73%
43.05
Current Liabilities
14.84
-58.14%
35.45
-34.57%
54.18
+31.50%
41.20
Payables And Accrued Expenses
1.20
-72.31%
4.32
-15.76%
5.13
+14.75%
4.47
Payables
0.68
+3.20%
0.66
-63.21%
1.79
-33.95%
2.70
Accounts Payable
0.68
+3.20%
0.66
-63.21%
1.79
-33.95%
2.70
Current Accrued Expenses
0.52
-85.86%
3.66
+9.61%
3.34
+89.35%
1.76
Pensionand Other Post Retirement Benefit Plans Current
1.20
+4.17%
1.15
-54.09%
2.51
+29.23%
1.94
Current Debt And Capital Lease Obligation
11.67
-60.58%
29.61
-35.29%
45.77
+31.54%
34.79
Current Debt
11.10
-61.86%
29.10
-34.16%
44.20
+31.35%
33.65
Other Current Borrowings
11.10
-61.86%
29.10
-34.16%
44.20
+31.35%
33.65
Current Capital Lease Obligation
0.57
+11.70%
0.51
-67.22%
1.56
+37.16%
1.14
Other Current Liabilities
0.77
+112.43%
0.36
-53.41%
0.78
Total Non Current Liabilities Net Minority Interest
1.68
-25.46%
2.25
-24.09%
2.96
+60.35%
1.85
Long Term Debt And Capital Lease Obligation
1.68
-25.46%
2.25
-24.09%
2.96
+60.35%
1.85
Long Term Capital Lease Obligation
1.68
-25.46%
2.25
-24.09%
2.96
+60.35%
1.85
Stockholders Equity
33.97
+1461.40%
-2.50
+95.37%
-53.83
-456.05%
-9.68
Common Stock Equity
9.29
+259.85%
-5.81
+89.77%
-56.82
-359.15%
-12.38
Capital Stock
24.68
+644.02%
3.32
+10.49%
3.00
+11.14%
2.70
Common Stock
0.00
+0.00%
0.00
-88.89%
0.01
+50.00%
0.01
Preferred Stock
24.68
+644.21%
3.32
+10.79%
2.99
+11.06%
2.69
Share Issued
0.93
+148.58%
0.37
+30.55%
0.29
+36.15%
0.21
Ordinary Shares Number
0.93
+148.58%
0.37
+30.55%
0.29
+36.15%
0.21
Additional Paid In Capital
268.02
+7.57%
249.15
+4.86%
237.60
+9.90%
216.19
Retained Earnings
-258.73
-1.48%
-254.97
+13.40%
-294.43
-29.04%
-228.17
Treasury Stock
0.00
-100.00%
0.41
Minority Interest
-11.67
-157.10%
-4.54
-115.22%
29.81
+44.62%
20.61
Total Equity Gross Minority Interest
22.30
+417.08%
-7.03
+70.72%
-24.02
-319.66%
10.93
Total Capitalization
33.97
+1461.40%
-2.50
+95.37%
-53.83
-456.05%
-9.68
Working Capital
-12.28
+63.10%
-33.28
-12.14%
-29.68
-1188.74%
2.73
Invested Capital
20.39
-12.45%
23.29
+284.48%
-12.62
-159.34%
21.27
Total Debt
13.35
-58.10%
31.86
-34.61%
48.73
+32.99%
36.64
Net Debt
9.56
-65.75%
27.91
+13.66%
24.56
Capital Lease Obligations
2.25
-18.55%
2.76
-39.01%
4.53
+51.49%
2.99
Net Tangible Assets
33.97
+1461.40%
-2.50
+95.48%
-55.26
-320.96%
-13.13
Tangible Book Value
9.29
+259.85%
-5.81
+90.02%
-58.25
-268.17%
-15.82
Current Notes Payable
Other Inventories
0.28
+150.45%
0.11
Preferred Stock Equity
24.68
+644.21%
3.32
+10.79%
2.99
+11.06%
2.69
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-5.21
+84.48%
-33.55
+35.52%
-52.04
+26.69%
-70.98
Cash Flow From Continuing Operating Activities
-5.21
+84.48%
-33.55
+35.52%
-52.04
+26.69%
-70.98
Net Income From Continuing Operations
-2.47
-108.69%
28.43
+135.86%
-79.26
+23.22%
-103.24
Depreciation Amortization Depletion
0.10
-91.24%
1.20
-59.14%
2.93
+19.33%
2.46
Depreciation
0.10
-83.57%
0.64
-29.86%
0.91
Amortization Cash Flow
0.00
-100.00%
0.56
-72.34%
2.02
Depreciation And Amortization
0.10
-91.24%
1.20
-59.14%
2.93
+19.33%
2.46
Amortization Of Intangibles
0.00
-100.00%
0.56
-72.34%
2.02
Other Non Cash Items
3.78
+2523.61%
0.14
-98.36%
8.78
+58.37%
5.55
Stock Based Compensation
1.71
-73.53%
6.45
-42.10%
11.14
-42.97%
19.53
Operating Gains Losses
-8.43
+88.01%
-70.28
-2626.38%
2.78
-48.80%
5.43
Gain Loss On Sale Of PPE
0.00
+100.00%
-1.00
0.00
Change In Working Capital
0.10
-80.86%
0.51
-67.82%
1.59
+322.21%
-0.72
Change In Receivables
0.00
-93.02%
0.04
+197.73%
-0.04
-124.04%
0.18
Changes In Account Receivables
0.00
-93.02%
0.04
+197.73%
-0.04
-124.04%
0.18
Change In Prepaid Assets
0.11
-86.90%
0.83
+438.21%
-0.25
-161.96%
0.40
Change In Payables And Accrued Expense
-0.01
+96.14%
-0.36
-119.30%
1.88
+245.14%
-1.30
Change In Accrued Expense
-0.04
+87.50%
-0.30
-110.86%
2.80
+605.23%
-0.55
Change In Payable
0.02
+140.68%
-0.06
+93.57%
-0.92
-23.72%
-0.74
Change In Account Payable
0.02
+140.68%
-0.06
+93.57%
-0.92
-23.72%
-0.74
Investing Cash Flow
-0.03
+99.81%
-16.18
-2235.09%
0.76
+115.99%
-4.74
Cash Flow From Continuing Investing Activities
-0.03
+99.81%
-16.18
-2235.09%
0.76
+115.99%
-4.74
Net PPE Purchase And Sale
-0.03
+43.64%
-0.06
+77.27%
-0.24
+84.29%
-1.54
Purchase Of PPE
-0.03
+43.64%
-0.06
+77.27%
-0.24
+84.29%
-1.54
Capital Expenditure
-0.03
+43.64%
-0.06
+77.27%
-0.24
+84.29%
-1.54
Net Business Purchase And Sale
0.00
+100.00%
-16.48
0.00
+100.00%
-3.20
Purchase Of Business
0.00
+100.00%
-16.48
0.00
+100.00%
-3.20
Gain Loss On Sale Of Business
0.00
+100.00%
-72.29
0.00
Net Intangibles Purchase And Sale
0.00
-100.00%
0.35
-65.00%
1.00
0.00
Net Other Investing Changes
-3.20
Financing Cash Flow
5.59
-82.13%
31.28
+0.36%
31.17
-18.42%
38.21
Cash Flow From Continuing Financing Activities
5.59
-82.13%
31.28
+0.36%
31.17
-18.42%
38.21
Net Issuance Payments Of Debt
0.00
+100.00%
-0.53
-105.35%
9.92
-71.84%
35.23
Issuance Of Debt
0.00
-100.00%
10.00
-71.61%
35.23
Repayment Of Debt
0.00
+100.00%
-0.53
-572.15%
-0.08
0.00
Long Term Debt Issuance
Long Term Debt Payments
0.00
Net Long Term Debt Issuance
0.00
Short Term Debt Issuance
0.00
-100.00%
10.00
-71.61%
35.23
Short Term Debt Payments
0.00
+100.00%
-0.53
-572.15%
-0.08
0.00
Net Short Term Debt Issuance
0.00
+100.00%
-0.53
-105.35%
9.92
-71.84%
35.23
Net Common Stock Issuance
5.70
+256.63%
1.60
-12.05%
1.82
+19.54%
1.52
Common Stock Payments
0.00
+100.00%
-0.37
Repurchase Of Capital Stock
0.00
+100.00%
-0.37
Proceeds From Stock Option Exercised
0.00
-100.00%
0.42
-48.27%
0.81
-44.67%
1.46
Net Other Financing Charges
-0.11
Changes In Cash
0.35
+101.91%
-18.45
+8.21%
-20.11
+46.41%
-37.51
Beginning Cash Position
1.19
-93.97%
19.64
-50.59%
39.74
-48.56%
77.26
End Cash Position
1.54
+29.79%
1.19
-93.97%
19.64
-50.59%
39.74
Free Cash Flow
-5.24
+84.42%
-33.61
+35.71%
-52.28
+27.92%
-72.53
Common Stock Issuance
5.70
+256.63%
1.60
-12.05%
1.82
-3.66%
1.89
Earnings Losses From Equity Investments
-8.48
-1494.55%
-0.53
0.00
Issuance Of Capital Stock
5.70
-81.85%
31.40
+53.59%
20.44
+983.88%
1.89
Net Preferred Stock Issuance
0.00
-100.00%
29.80
+59.99%
18.62
0.00
Preferred Stock Issuance
0.00
-100.00%
29.80
+59.99%
18.62
0.00
Sale Of Intangibles
0.00
-100.00%
0.35
-65.00%
1.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category